Patrick Rossignol
Inventor
Stats
- 2 US patents issued
- 7 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 2 US Patents Issued
- 7 US Applications Filed
- 5 Total Citation Count
- Oct 12, 2018 Most Recent Filing
- Jun 15, 2012 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
CENTRE HOSPITALIER ET UNIVERSITAIRE DE NANCY (CHU) | 3
1 | 2013
2017 |
CHU DE NANCY | 2
| 2012
|
Cantre Hospitalier et Universitaire de Nancy (CHU) | 1
| 2013
|
UNIVERSITE PARIS DESCARTES | 2
2 1 | 2012
2013 2017 |
UNIVERSITE PARIS DIDEROT - PARIS 7 | 2
1 | 2013
2017 |
Centre Hospaitalier et de Nancy (CHU) | 1
| 2012
|
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) | 1
3 1 | 2012
2013 2017 |
UNIVERSITE DE LORRAINE | 1
3 1 | 2012
2013 2017 |
CENTRE HOSPITALIER ET UNIVERSITAIRE DE NANCY (CHU) | 1
| 2012
|
Inventor Addresses
Address | Duration |
---|---|
Nancy, FR | Sep 12, 19 - Sep 12, 19 |
Vandoeuvre Les Nancy, FR | May 01, 14 - Jan 01, 15 |
Vandoeuvre les Nancy, FR | Sep 01, 15 - Sep 01, 15 |
Vandoeuvre-les-nancy, FR | Sep 03, 15 - Jan 01, 19 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 3 |
C07K: | PEPTIDES | 3 |
C12N: | MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF | 2 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2019/0279,770 | 2019 | SOLUBLE ST2 FOR THE IDENTIFICATION OF PROGRESSORS TO LVH IN THE GENERAL POPULATION | 0 |
10167468 | 2019 | Methods for the treatment of cardiovascular fibrosis | 0 |
2017/0166,892 | 2017 | Methods and Pharmaceutical Compositions for the Treatment of Cardiovascular Fibrosis | 0 |
9594083 | 2017 | Method for the treatment of cardiovascular fibrosis | 1 |
2015/0247,855 | 2015 | Methods and Pharmaceutical Compositions for the Treatment of Cardiovascular Fibrosis | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.